- Stocks
- Pharma & Healthcare
- Viyash Scientific
Viyash Scientific share price
NSE: VIYASHPharma & HealthcareDrug Manufacturers - Specialty & Generic
Viyash Scientific at a glance
Viyash Scientific (NSE: VIYASH) closed at ₹214.90 on 22 Oct 2026, down 0.05% on the day. With a market capitalisation of ₹9,388 Cr, it ranks 572nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
At its last close the stock traded at 53.6× trailing earnings, against a return on equity of 3.1% in FY25. Over the past year the share price has risen 3.1%. Its 52-week range is ₹178.13 (23 Mar 2026) to ₹298.00 (6 Jul 2026); the last close is 27.9% below the high. Promoters held 61.31% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹9,388 CrRank 572 on NSE
- P/E (trailing)
- 53.6×
- Price to book
- 4.65×FY25
- ROE
- 3.1%FY25
- ROCE
- 10.0%FY25
- Debt to equity
- 0.63FY25
- Net profit margin
- 2.1%FY25
- Book value / share
- ₹28.15FY25
- 52-week high
- ₹298.006 Jul 2026
- 52-week low
- ₹178.1323 Mar 2026
- 1-year return
- +3.1%
- RSI (14-day)
- 28.2
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −0.05% | −7.9% | −14.3% | −16.2% | +3.1% |
Viyash Scientific financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹1,179 Cr | ₹1,362 Cr | ₹1,413 Cr | ₹1,421 Cr | ₹1,370 Cr | ₹1,551 Cr |
| Operating profit | ₹94 Cr | ₹145 Cr | ₹53 Cr | −₹73 Cr | −₹37 Cr | ₹49 Cr |
| Net profit | ₹82 Cr | ₹104 Cr | ₹45 Cr | −₹122 Cr | −₹30 Cr | ₹32 Cr |
| EPS (₹) | ₹3.00 | ₹4.00 | ₹2.00 | −₹5.00 | −₹1.00 | ₹1.00 |
| Cash from operations | ₹115 Cr | ₹115 Cr | ₹31 Cr | ₹17 Cr | ₹31 Cr | ₹83 Cr |
| Total debt | ₹150 Cr | ₹94 Cr | ₹122 Cr | ₹183 Cr | ₹143 Cr | ₹274 Cr |
| Shareholders' equity | ₹743 Cr | ₹728 Cr | ₹683 Cr | ₹699 Cr | ₹657 Cr | ₹704 Cr |
Viyash Scientific shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 16 Dec 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 52.61% | 52.33% | 61.43% | 61.41% | 61.31% | 61.31% |
| Foreign institutions | 6.15% | 5.91% | 3.16% | 3.16% | 2.94% | 4.50% |
| Domestic institutions | 12.99% | 12.91% | 7.35% | 7.36% | 7.99% | 3.75% |
| Non-institutions | 28.10% | 28.69% | 27.97% | 27.97% | 27.67% | 30.34% |
Viyash Scientific vs peers
The listed Pharma & Healthcare companies nearest to Viyash Scientific by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| AKUMSAkums Drugs and Pharmaceuticals | ₹690.85 | −0.17% | +50.2% | ₹10,874 Cr | 41.5 | — |
| PARKHOSPSPark Medi World | ₹220.45 | −0.74% | — | ₹9,522 Cr | 32.1 | — |
| BLUEJETBlue Jet Healthcare | ₹499.60 | +1.50% | −23.8% | ₹9,456 Cr | 35 | — |
| VIYASHViyash Scientific | ₹214.90 | −0.05% | +3.1% | ₹9,388 Cr | 53.6 | — |
| STARStrides Pharma Science | ₹1,017.30 | −1.23% | +27.8% | ₹9,377 Cr | 16.9 | — |
| YATHARTHYatharth Hospital & Trauma Care Services | ₹932.10 | +1.22% | +14.4% | ₹8,981 Cr | 51.2 | — |
| HCGHealthcare Global Enterprises | ₹552.00 | +0.60% | −19.8% | ₹8,241 Cr | — | — |
Ask anything about Viyash Scientific
Pivot answers on the live chart with evidence you can check, and tests strategies against VIYASH's own history. Try: “Why has VIYASH moved over the last three months?” · “Backtest a 50-day moving-average crossover on VIYASH over five years” · “Compare VIYASH with AKUMS on margins and valuation”
Frequently asked questions about Viyash Scientific
What is the share price of Viyash Scientific today?
Viyash Scientific (NSE: VIYASH) last closed at ₹214.90 on 22 Oct 2026. Its 52-week high is ₹298.00 and its 52-week low is ₹178.13.
What is the market cap of Viyash Scientific?
Viyash Scientific's market capitalisation is ₹9,388 Cr (₹9,388 Cr) at the 22 Oct 2026 close, ranking 572nd among the NSE companies Pivot tracks.
What is the P/E ratio of Viyash Scientific?
Viyash Scientific trades at a trailing P/E of 53.6. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 35.
What is the ROE and ROCE of Viyash Scientific?
Return on equity was 3.1% in FY25 and return on capital employed was 10.0% in FY25 (consolidated figures).
Is Viyash Scientific a debt-free company?
No. Viyash Scientific's debt-to-equity ratio was 0.63 in FY25, with total debt of ₹274 Cr.
How has Viyash Scientific stock performed over the last year?
Viyash Scientific's share price has risen 3.1% over the past year, −16.2% over three months and −14.3% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Viyash Scientific?
As of 30 Jun 2026: promoters 61.31%, foreign institutions 4.50%, domestic institutions 3.75%, non-institutions 30.34%.
Who are Viyash Scientific's competitors?
The listed Pharma & Healthcare companies closest to Viyash Scientific by market cap are Akums Drugs and Pharmaceuticals, Park Medi World, Blue Jet Healthcare, Strides Pharma Science, Yatharth Hospital & Trauma Care Services and Healthcare Global Enterprises.
Is Viyash Scientific a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Viyash Scientific's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on VIYASH against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with V · all NSE stocks · this page as text